ARTICLE
The distinctive syndrome of HenochSchoenlein purpura (HSP) was first described by Heberden before 1800, and in 1808 English physician Robert Willan described a patient who had swollen, painful joints and a rash. The syndrome owes its name to two German physicians.
In 1837, Johan Schoenlein described several cases of purpura associated with arthritis, which he termed "peliosis rheumatica."
In 1868, Edouard Henoch pointed out that the term "peliosis rheumatica" was inappropriate and restrictive because patients who had urticarial purpura and acute arthritis also manifested gastrointestinal symptoms, such as vomiting, colicky abdominal pain, and melena. He described four children who had purpura, colicky abdominal pain, gastrointestinal hemorrhage, and joint pain as well as renal involvement) Since these first descriptions, HSP also has been referred to as anaphylactoid, al- The incidence of HSP is greater in males, with a male-to-female ratio of 1.5 to 2.0:1. In adults, the sex ratio approaches 1 : 1. There appears to be a seasonal incidence, with more cases in the spring and autumn months.
Recent reports indicate that HSP may be less common in black than white children.4 Pulmonary hemorrhage with hemoptysis has been described, as has hemorrhage into large muscle groups, which may produce excruciating pain.20 '2' CENTRAL NERVOUS
Etiology

SYSTEM
The central nervous system may suffer from the combined effects of vasculitis and hemorrhagic diathesis. In 1914, Osler reported a child who had allergic purpura associated with hemiplegia.
Central nervous system involvement is distinctly uncommon; when it occurs, the most common symptom is headache ( 
Differential Diagnosis
The full-blown picture of HSP-featuring typical rash, arthritis, and gastrointestinal and renal manifestations-is diagnostic. Diagnostic difficulties arise when one symptom predominates or multiple system involvement is not recognized. The elements of the differential diagnosis of HSP and the appropriate laboratory tests are listed in Table 4 .
Laboratory
Findings
Diagnosis of HSP depends primarily on clinical findings and history. Laboratory tests are helpful but nondiagnostic (Table 5) . A complete blood count may reveal a normal or dcvated white blood cell count and eosinophilia.
Anemia may occur 5cc-ondary to acute bleeding. Erythrocyte sedimentation rate and platelet count may be elevated in association with acute inflammation.
Electrolytes may be affected secondary to gastrointestinal involvement.
Serum amylase would be elevated in association with pancreatitis.
The hemorrhagic diathesis of HSP is secondary to decreased factor VI!! levels that may not be reflected in routine prothrombin and partial thromboplastin times. Routine urinalysis may show hematuria, but any evidence of proteinuria should prompt measurement of 24-h urine protein excretion or measurement of the ratio of urine protein to creatinine, and a serum albumin level should be determined. Because renal manifestations may follow the onset of the illness by up to 3 mo, urinalysis should be performed monthly for 3 mo to exclude this late complication.
Blood urea nitrogen and creatinine levels will be elevated when there is associated renal involvement with renal insufficiency. Renal biopsy should be carried out where indicated.
Tests for stool guaiac must be 
Prognosis
In the absence of renal disease and major central nervous system involvement, the prognosis for individuals who have HSP is excellent.
The illness lasts 4 to 6 wk in the majority of cases. Recurrences, which occur in half the patients, usually occur within 6 wk, but may be noted as late as 7 y after the onset of illness. Children younger than 3 y tend to have a shorter, milder course and fewer recurrences.
In rare cases, long-term morbidity occurs because of residual central nervous system damage.
Long-term follow-up is necessary in patients who have renal involvement because progression of renal disease may not occur for many years. Microscopic hematuria alone is associated with good long-term prognosis, but more severe renal involvement has a variable outcome. A poor prognosis with progression to renal failure has been associated with the onset of HSP nephritis in children older than 6 y, the development of the nephrotic syndrome, and the presence of crescent formation in more than 50% of the glomeruli. A renal biopsy can help to establish the diagnosis and determine prognosis.
